Patent · US Active

Porphyrin compounds and compositions useful for treating cancer

US11590233B2 · kind B2 · utility

0Cited by
44References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2018
Grant dateFeb 28, 2023
Priority date—
Expiry dateDec 17, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A porphyrin compound of Formula III

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.